Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IDev Technologies
Webster, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
IDev Technologies developed SUPERA/SUPERA Veritas, a self-expanding nitinol stent system approved in Europe (CE Mark) for treating peripheral artery disease and approved in the US for biliary strictures. The company was conducting the SUPERB IDE trial to study the stent's safety and efficacy in superficial femoral artery applications.[1][2]
- Therapeutic areas
- CardiovascularGastroenterology
- Modalities
- Device
- Industry
- Implantable Medical Devices
Beyond the preview
Go deeper on IDev Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IDev Technologies.